Kamada (KMDA) Retained Earnings (2012 - 2026)
Kamada (KMDA) reported Retained Earnings of -$27.4 million for Q1 2026, up 17.85% on a YoY basis from -$23.2 million in Q1 2025, and down 60.26% quarter-over-quarter from -$17.1 million in Q4 2025.
Kamada (KMDA) Retained Earnings (2012 - 2026) Analysis & Trends
Kamada has reported Retained Earnings for 15 years, with the latest figure at -$27.4 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 17.85% year-over-year to -$27.4 million; the trailing twelve-month figure through Mar 2026 stood at -$27.4 million (up 17.85% YoY), and the FY2025 full-year result was -$17.1 million, up 33.66% from the prior year.
- Retained Earnings for Q1 2026 stood at -$27.4 million, down from -$17.1 million in the prior quarter.
- The five-year high for Retained Earnings was -$50293.0 in Q1 2023, with the low at -$51.9 million in Q2 2022.
- Historically, Retained Earnings has averaged -$31.4 million across 5 years, with a median of -$33.3 million in 2025.
- The largest YoY upside for Retained Earnings was 99.9% in 2023 against a maximum downside of 87902.64% in 2023.
- Kamada's Retained Earnings stood at -$48.5 million in 2022, then gained by 17.09% to -$40.2 million in 2023, then surged by 35.98% to -$25.7 million in 2024, then jumped by 33.66% to -$17.1 million in 2025, then sank by 60.26% to -$27.4 million in 2026.
- The last three Retained Earnings figures came in at -$27.4 million (Q1 2026), -$17.1 million (Q4 2025), and -$20.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn | -27.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.36 Mn |
| Dec 31, 2025 | -17.07 Mn |
| Sep 30, 2025 | -20.64 Mn |
| Jun 30, 2025 | -25.93 Mn |
| Mar 31, 2025 | -33.31 Mn |
| Dec 31, 2024 | -25.74 Mn |
| Sep 30, 2024 | -29.55 Mn |
| Jun 30, 2024 | -33.41 Mn |
| Mar 31, 2024 | -37.84 Mn |
| Dec 31, 2023 | -40.20 Mn |
| Sep 30, 2023 | -45.26 Mn |
| Jun 30, 2023 | -48.48 Mn |
| Mar 31, 2023 | -50,293.00 |
| Dec 31, 2022 | -48.48 Mn |
| Sep 30, 2022 | -51,428.00 |
| Jun 30, 2022 | -51.91 Mn |
| Mar 31, 2022 | -47.99 Mn |
| Dec 31, 2021 | -46.16 Mn |
| Sep 30, 2021 | -41.15 Mn |
| Jun 30, 2021 | -40.31 Mn |